A 24-year-old male, working as a boilerman on a warship, with a hairy body surface, presented to our emergency department with progressively worsening headaches and diplopia for 2 weeks. Initial computed tomography (CT) of the brain revealed a mass with contrast enhancement in the posterior area of the third ventricle. Magnetic resonance imaging (MRI) of the brain revealed a heterogeneously enhancing pineal region mass lesion with obstructive hydrocephalus as shown in
Figure 1. Serum samples showed extremely high levels of tumor markers, such as β-HCG and AFP. Surgical intervention with external ventricular drainage was performed as a strategy for CSF diversion, followed by an endoscopy-assisted suboccipital infratentorial approach with the removal of the tumor for cytoreduction, as shown on the brain CT 3 days post-operatively (
Figure 2). The frozen section suggested a pineal germinoma, in accordance with its histomorphological pattern. Immunohistochemical staining revealed high expression of glial fibrillary acidic protein, SALL-4 (sal-like protein 4), and placental-like alkaline phosphatase (PLAP) in the pineal tumor, which was confirmed to be a pineal germinoma (
Figure 3).
In the first postoperative week, the patient was capable of following instructions, even with the endotracheal tube and EVD in place, as a precaution against postoperative cerebral edema. During this period, the Karnofsky performance score (KPS) was 60. However, 2 weeks after surgical intervention, the Glasgow coma scale deteriorated to 7 from the normal level. Moreover, the KPS dropped to 20, accompanied by Parinoud’s syndrome. Thus, an emergency endotracheal tube was inserted due to impaired consciousness. A repeated MRI of the brain showed an enlarging heterogeneous enhancing mass, measuring 4.4 × 3.0 × 4.0-cm, occupying the pineal region and tectal plate and displacing the vein of Galen and inferior sagittal sinus with perifocal edema in bilateral thalamus and right basal ganglion as shown in
Figure 4, compared with preoperative imaging. After explaining the outcome and risk of the subsequent therapeutic strategy to his family, chemotherapy with etoposide (600 mg) and cisplatin (140 mg) followed by ifosfamide (8000 mg) was administered in divided doses for 4 days with simultaneous intensive ventilation support. Unexpectedly, the patient recovered rapidly after chemotherapy. The tumor size dramatically decreased, as observed on MRI scan, with three cycles of chemotherapy. Moreover, radiotherapy with a total dose of 24 Gy in 22 fractions was administered over 3 weeks to the gross tumor before chemotherapy, followed by a local boost total dose of 16 Gy in 10 fractions over 2 weeks to the residual tumor after chemotherapy.
MRI performed 3 months after chemotherapy showed complete remission of the pineal germinoma as shown in
Figure 5. The patient’s neurological function recovered well. Twelve months after chemotherapy, at outpatient follow-up, MRI demonstrated no tumor relapse, accompanied by β-HCG and AFP levels within the normal range (
Figure 6). The patient was completely independent and actively participated in military career.
Primary germ cell tumors represent 0.4% of CNS tumors. Germinomas, the most prevalent subtype, often arise in the pineal region. They can also appear in suprasellar, bifocal, basal ganglia, or multifocal areas [
1,
2,
3]. Surgical biopsy via open or stereotactic biopsy for tissue diagnosis plays a significant role in the diagnosis and management of pineal tumors because of the lack of specific imaging characteristics. Intracranial germinomas respond well to radiation, with combined chemotherapy and radiotherapy yielding excellent outcomes [
4,
5,
6,
7]. If a pineal region tumor is homogeneously enhanced and has the classic appearance of germinoma on MRI with isointensity relative to CSF and elevated β-HCG and AFP, which is essential for the diagnosis of germinoma, a test dose of 5 Gy may be administered. If the tumor shrinks, the diagnosis of germinoma is almost certain and radiotherapy may be continued without surgery [
8,
9]. However, this approach may obey institutional policies, and some centers do not offer chemotherapy and radiotherapy to patients without histological confirmation. Patients with pineal germinoma often present with obstructive hydrocephalus. Surgical interventions like ventricular peritoneal shunt or endoscopic third ventriculostomy alleviate symptoms and offer a chance for a pathological diagnosis [
10] However, the endoscopy-assisted biopsy diagnosis of a pineal tumor, given its histological heterogeneity, seems to have limitations in accurately representing the entire tumor. Therefore, in this case, the decision to proceed with tumor removal was made not only to achieve cytoreduction but also to obtain the most extensive specimen possible for a comprehensive histological diagnosis. Even with the best efforts secure sufficient tumor tissue for diagnostic confirmation, there remains a possibility that the tumor could be a mixed cell-type germ cell tumor.
The reason for pineal germinoma’s swift growth post-surgery is unclear. In our observation, the tumor had a significant blood supply, potentially leading to rapid growth. Devascularization is recommended during tumor removal [
11] Pineal germinomas risk CSF seeding, with most relapses in the periventricular area. Whole-brain radiation results in 8% recurrence, while focal radiation has 23%. CSF flow influences both tumor seeding and growth [
12,
13]. We report a case of a pineal germinoma manifesting with dramatic size changes. Given germinomas’ responsiveness to chemotherapy and radiotherapy, early aggressive chemotherapy is advised, especially when large tumors and neurological issues are not due to obstructive hydrocephalus. Despite the tumor’s size and vascularity, chemotherapy and radiotherapy post-diagnosis are prioritized over surgical reduction, even in comatose patients.
Author Contributions
Conception and design: K.-Y.T.; acquisition of data: C.-J.H. and H.-C.L.; analysis and interpretation of data: C.-J.H. and H.-C.L.; drafting the article: C.-J.H.; critically revising the article: K.-Y.T. and D.-Y.H.; reviewed submitted version of manuscript: K.-Y.T.; approved the final version of the manuscript on behalf of all authors (corresponding author only): K.-Y.T.; statistical analysis: C.-J.H.; administrative/technical/material support: D.-Y.H.; study supervision: D.-Y.H. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee of Tri-Service General Hospital for studies involving humans. Protocol code: A202105211. Date of approval: 3 January 2022.
Informed Consent Statement
Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Data Availability Statement
The data presented in this study are available on request from the corresponding author. The data are no publicly available due to restrictions of privacy.
Acknowledgments
I am grateful to all of those with whom I have had the pleasure to work during this and other related projects. Each of the members of the Department of Neurological Surgery, Tri-Service General Hospital has provided me extensive personal and professional guidance and taught me a great deal about both scientific research and life in general. I would especially like to thank Kuan-Yin Tseng, my tutor. As my teacher and mentor, he has taught me more than I could ever give him credit for here. He has shown me, by his example, what a good doctor should be.
Conflicts of Interest
The authors declare no conflict of interest.
Abbreviations
AFP | α-fetoprotein |
CNS | central nervous system |
CT | computed tomography |
GCT | germ cell tumor |
KPS | Karnofsky performance score |
MRI | magnetic resonance imaging |
PLAP | placental-like alkaline phosphatase |
β-HCG | β-human chorionic gonadotropin |
References
- Lee, S.H.; Jung, K.-W.; Ha, J.; Oh, C.-M.; Kim, H.; Park, H.J.; Yoo, H.; Won, Y.-J. Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005–2012. Cancer Res. Treat 2017, 49, 494–501. [Google Scholar] [CrossRef] [PubMed]
- McCarthy, B.J.; Shibui, S.; Kayama, T.; Miyaoka, E.; Narita, Y.; Murakami, M.; Matsuda, A.; Matsuda, T.; Sobue, T.; Palis, B.E.; et al. Primary CNS germ cell tumors in Japan and the United States: An analysis of 4 tumor registries. Neuro. Oncol. 2012, 14, 1194–1200. [Google Scholar] [CrossRef] [PubMed]
- Ostrom, Q.T.; Gittleman, H.; Liao, P.; Rouse, C.; Chen, Y.; Dowling, J.; Wolinsky, Y.; Kruchko, C.; Barnholtz-Sloan, J. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro. Oncol. 2014, 16 (Suppl. S4), iv1–iv63. [Google Scholar] [CrossRef] [PubMed]
- Nguyen, Q.; Chang, E.L.; Allen, P.K.; Maor, M.H.; Ater, J.L.; Mahajan, A.; Wolff, J.E.A.; Weinberg, J.S.; Woo, S.Y. Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer 2006, 107, 2228–2236. [Google Scholar] [CrossRef] [PubMed]
- Paximadis, P.; Hallock, A.; Bhambhani, K.; Chu, R.; Sood, S.; Wang, Z.; Konski, A. Patterns of failure in patients with primary intracranial germinoma treated with neoadjuvant chemotherapy and radiotherapy. Pediatr. Neurol. 2012, 47, 162–166. [Google Scholar] [CrossRef] [PubMed]
- Takano, S.; Yamamoto, T.; Ishikawa, E.; Akutsu, H.; Nakai, K.; Matsuda, M.; Muroi, A.; Shibata, Y.; Mizumoto, M.; Tsuboi, K.; et al. Improvement of Long-term Results with Neoadjuvant Chemotherapy and Radiotherapy for Central Nervous System Germinoma. World Neurosurg. 2015, 84, 846–854. [Google Scholar] [CrossRef] [PubMed]
- Wilkening, G.N.; Madden, J.R.; Barton, V.N.; Roberts, A.; Foreman, N.K. Memory deficits in patients with pediatric CNS germ cell tumors. Pediatr. Blood Cancer 2011, 57, 486–491. [Google Scholar] [CrossRef] [PubMed]
- Oi, S.; Matsuzawa, K.; Choi, J.U.; Kim, D.S.; Kang, J.K.; Cho, B.K. Identical characteristics of the patient populations with pineal region tumors in Japan and in Korea and therapeutic modalities. Childs Nerv. Syst. 1998, 14, 36–40. [Google Scholar] [CrossRef] [PubMed]
- Regis, J.; Bouillot, P.; Rouby-Volot, F.; Figarella-Branger, D.; Dufour, H.; Peragut, J.C. Pineal region tumors and the role of stereotactic biopsy: Review of the mortality, morbidity, and diagnostic rates in 370 cases. Neurosurgery 1996, 39, 907–914. [Google Scholar] [PubMed]
- Souweidane, M.M.; Krieger, M.D.; Weiner, H.L.; Finlay, J.L. Surgical management of primary central nervous system germ cell tumors: Proceedings from the Second International Symposium on Central Nervous System Germ Cell Tumors. J. Neurosurg. Pediatr. 2010, 6, 125–130. [Google Scholar] [CrossRef]
- Jung, T.Y.; Baek, H.J.; Kim, S.K.; Lee, K.H. Staged operations for a hypervascular mixed germ cell tumor with growing teratoma syndrome: A case report. Childs Nerv. Syst. 2022, 38, 11–16. [Google Scholar] [CrossRef]
- Alapetite, C.; Brisse, H.; Patte, C.; Raquin, M.A.; Gaboriaud, G.; Carrie, C.; Habrand, J.L.; Thiesse, P.; Cuilliere, J.C.; Bernier, V.; et al. Pattern of relapse and outcome of non-metastatic germinoma patients treated with chemotherapy and limited field radiation: The SFOP experience. Neuro. Oncol. 2010, 12, 1318–1325. [Google Scholar] [PubMed]
- Rogers, S.J.; Mosleh-Shirazi, M.A.; Saran, F.H. Radiotherapy of localised intracranial germinoma: Time to sever historical ties? Lancet Oncol. 2005, 6, 509–519. [Google Scholar] [CrossRef] [PubMed]
| Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).